Nektar Therapeutics has announced a one-for-fifteen reverse stock split of its common stock, set to take effect on June 8, 2025, at 11:59 p.m. Eastern Time. Trading on a split-adjusted basis will commence on June 9, 2025, under the existing ticker "NKTR" and a new CUSIP number 640268306. The reverse stock split will consolidate every fifteen shares of common stock into one share, with adjustments made for fractional shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.